Nonclinical Consulting
- Program Objective
- This program supports early-stage strategy development and expert consulting to improve the success rate of domestic drug development and strengthen Korea's biohealth competitiveness during the critical preclinical stage.
- Program Details
- Provides tailored consulting to minimize challenges in the nonclinical development stage and support successful transition to clinical trials.
- Program Period: Apr-Nov, 2026
- Scope of Support:
- Nonclinical development strategy consulting
- Study design and protocol review
- Gap analysis and next-stage planning
- Evaluation of additional study needs and timelines
- Contact
R&D Enabling & Strategy Team: rnd_project@kddf.org